Abstract. Traditional medicinal plants are widely used as immunomodulatory medicines that help improve health. A total of 50 different plants used for the treatment of toxicity were screened for their in vivo protective effects. Flies were fed a standard cornmeal-yeast medium (control group) or the standard medium containing medicinal plant extracts (experimental groups). Assessment of the survival rate was performed by feeding flies with toxic compounds. Gut epithelial cells were analyzed for cell proliferation and death by green fluorescent protein antibodies and 7-aminoactinomycin D staining under the microscope. The expression of antimicrobial peptides (AMPs) was evaluated by the quantitative polymerase chain reaction and the results revealed that after feeding the flies with toxic compounds, aqueous extracts from Codonopsis pilosula (Franch.) Nannf (C. pilosula), Saussurea lappa (Decne.) C.B.Clarke (S. lappa), Imperata cylindrica Beauv.var. major (Nees) C.E. Hubb. (I. cylindrical var. major) and Melia toosendan Sied. Et Zucc. (M.toosendan) increased the fly survival rate, reduced epithelial cell death and improved gut morphology. In addition, C. pilosula extracts induced the antimicrobial peptide levels (Dpt and Mtk) following treatment with sodium dodecyl sulfate (SDS). However, these extracts were not observed to increase SDS-induced cell proliferation in vivo. These results indicate that there are strong protective effects in extracts of C. pilosula, S. lappa, I. cylindrical var. major and M. toosendan on Drosophila intestinal cells among 50 medicinal plants.
Introduction
Immune responses to infection or injury are causes of systemic or local inflammation, respectively. Inflammation is a complex biological response leading to numerous diseases, including rheumatoid arthritis, chronic asthma, multiple sclerosis, inflammatory bowel disease and psoriasis (1) . Inflammatory bowel disease and ulcerative colitis in particular are chronic debilitating diseases that affect millions of people worldwide. Furthermore, Drosophila melanogaster is a well-established model organism for studying various diseases, including inflammatory bowel diseases (2) . Intestinal stem cells (ISCs) have been identified in Drosophila midgut and hindgut, which are equivalent to mammalian intestine and colon, respectively (3) . In order to maintain gut homeostasis, intestinal epithelial cells turn over rapidly following damage from ingested pathogens, chemicals and toxic compounds. In the Drosophila midgut, cell turnover is functionally equivalent to that occurring in the mammalian small intestine. An ISC divides into a new ISC and a post-mitotic enteroblast (EB), which differentiates into an absorptive enterocyte or a secretory enteroendocrine cell (4) . In addition, gut cell turnover is regulated by a balance between cell death and stem cell proliferation (5) .
In the Drosophila gut, the immune response primarily relies on the local production of microbicidal reactive oxygen species (ROS) and the release of antimicrobial peptides (AMPs) (6) . The production of ROS in the gut by the nicotinamide adenine dinucleotide phosphate oxidase Duox provides an efficient barrier against the majority of ingested microbes (7) . However, the excessive accumulation of ROS can disrupt mitochondrial DNA, protein oxidation and lipid peroxidation, which results in impaired function of the mitochondria and metabolism (8) . Furthermore, the local production of AMPs are important in the inducible defense mechanisms in the gut. AMPs are triggered by the Imd pathway through the recognition of Gram-negative peptidoglycan (9) .
Traditional, medicinal plants are globally used and have rapidly grown in economic importance. Intrinsically active compounds are well-known for their anti-oxidant, anti-tumor, anti-viral and anti-inflammatory activities, and for improving immunity in general (10) (11) (12) .
In the present study, Drosophila were used as a model organism in order to identify the protective effects of 50 different traditional medicinal plant extracts that are known to have curative or beneficial effects on the symptoms of various disorders in China. Investigating these medicinal plants, particularly the aqueous extracts of four species (C. pilosula, S. lappa, I. cylindrical var. major and M. toosendan), may help clinical researchers to improve their understanding of the complex roles of medicinal plants in gut disorders, including inflammatory bowel disease.
Materials and methods
Drosophila stocks. Drosophila melanogaster strains were cultured on a standard cornmeal-yeast medium at 25˚C and 60% humidity under a 12-h light/dark cycle. W 1118 was purchased from the Bloomington Drosophila stock center (Bloomington, IN, USA), and esg-Gal4 UAS-green fluorescent protein (GFP) antibodies was a gift from Dr Rongwen Xi (National Institute of Biological Sciences, Beijing, China).
Aqueous extracts of traditional medicinal plants and preparation of growth media.
A total of 50 different traditional medicinal plants were purchased from the Renmintongtai Pharmacy (Harbin, China). Aqueous plant extracts were obtained as previously described (11) . A total of 50 types of traditional medicinal plants (20 g ) were immersed in deionized water (200 ml; yield, ~5-14%) overnight at 25˚C. The aqueous extraction was boiled for 3 h, and the extraction process was repeated twice. The total extracts were mixed and concentrated to 100 ml. Flies fed a standard cornmeal-yeast medium were used as the control group. Flies fed the standard medium containing extracts of the medicinal plants served as the experimental groups. The final concentrations of the extracts ranged between 1.25 and 10% (w/v) ( Table I) .
Feeding experiments. The 4-to 5-day-old adult flies were used for the feeding experiments, with each vial containing 15 males and 15 females. Following a 2 h fast in an empty vial, flies were transferred into a vial with five layers of filter paper hydrated with 5% sucrose (w/v) with toxic compounds, containing 0.4 M NaCl, 0.6% SDS or 4% DSS. Filter papers were changed every day, and the number of living flies was recorded at each transfer for 6 or 8 days.
Reverse transcription-quantitative polymerase chain reaction (RT-qPCR).
Due to their larger size, female flies were used for gut dissection. The survival and gut cell development were similar in both females and males (3) . Adult females were treated with 1% SDS for 0, 4 or 16 h. In addition, the total RNA was extracted from 25-30 dissected guts (without Malpighian tubules) using TRIzol reagent (Invitrogen; Thermo Fisher Scientific, Inc., Waltham, MA, USA), and cDNA was synthesized via RT using M-MLV reverse transcriptase, RNase H minus and a point mutant kit (Promega Corporation, Madison, WI, USA). qPCR was performed in a total reaction volume of 20 µl with 3 µl DDW, 3 µl PCR primer, 10 µl master mix (2X) and 5 µl template cDNA. Lightcycler 480 SYBR Green I Master Mix was used (Roche Diagnostics, Basel, Switzerland). qPCR thermal cycling conditions were as follows: 95˚C for 5 min, followed by 40 cycles of 95˚C for 10 sec, 55˚C for 10 sec and 72˚C for 10 sec, and one melting curve cycle of 95˚C for 5 sec, 65˚C for 1 min and continuous 97˚C, followed by 40˚C for 10 sec. Results were normalized to the level of RpL32 mRNA in each sample from two independent experiments using LightCycler 480 software version 1.5 (Roche Diagnostics). Primer sequences are depicted in Table II .
Im m u n osta i n i ng. D ead c el ls were det e ct e d by 7-aminoactinomycin D (7-AAD; Invitrogen; Thermo Fisher Scientific, Inc.); gut imaging and staining were performed as described previously (11) . Briefly, guts of adult females were dissected in cold phosphate-buffered saline (PBS), incubated in 7-AAD (5 µg/ml in PBS) for 30 min at room temperature, and washed with PBS three times. For immunostaining, dissected guts of female flies were fixed in 4% paraformaldehyde for 30 min at room temperature. Samples were blocked with 5% goat serum in PBS-Tween 20 (Sigma-Aldrich; Merck Millipore, Darmstadt, Germany) for 30 min followed by incubation with polyclonal anti-GFP antibodies synthesized in our laboratory (1:200) overnight at 4˚C. Following washing four times with PBS with Tween 20, samples were incubated with anti-rat IgG-fluorescein isothiocyanate secondary antibody (1:200; F1763; Sigma-Aldrich; Merck Millipore) for 2 h at room temperature adn subsequently stained with 4',6-diamidino-2-phenylindole (Sigma-Aldrich; Merck Millipore) for 10 min. Finally, the guts were mounted in 70% glycerol and imaged with an Axioskop 2 plus microscope (Zeiss AG, Oberkochen, Germany). All the data are representative of three independent experiments. The number of dead cells, intestinal stem cells and enteroblasts in the Drosophila gut was quantified using ImageJ software (V1.47; National Institutes of Health, Bethesda, MD, USA).
Statistical analysis. Statistical analysis was performed using a two-tailed unpaired Student's t-test with Prism Prism 6 software (GraphPad Software, Inc., La Jolla, CA, USA). P<0.005 was considered to indicate a statistically significant difference. Error bars indicate the mean ± standard error of the mean.
Results

Medicinal plant extracts improve survival rates in vivo.
The intestinal epithelium is susceptible to damage caused by pathogens, oxidative stress and toxic compounds. Foods containing SDS or NaCl could cause injury to the intestines and result in a melanotic phenotype in Drosophila (13) . To screen for protective activities of traditional medicinal plants, flies were fed a standard cornmeal medium supplemented with (experimental groups) or without (control group) aqueous extracts of the medicinal plants. Adult flies from each of the culture conditions were orally treated with the inflammatory reagent SDS or NaCl. Initially, a vial containing 30 adult flies from each culture condition was treated with 0.6% SDS, and the survival rate was assessed over 6 days (Table III) . The control group revealed >88% mortality, however, a number of flies in the experimental groups appeared to have an increased survival rate. Out of 50 different medicinal plant extracts, 16 species increased the survival rate by >50% compared with the control group (Fig. 1A) . In addition, following treatment with 0.4 M NaCl, 18 species increased in survival rate by 50% compared with the control (Fig. 1B and Table IV) .
In other experiments, four plant extracts that revealed a higher fly survival rate following treatment with SDS or NaCl, including Codonopsis pilosula (Franch.) Nannf (C. pilosula), Saussurea lappa (Decne.) C.B.Clarke (S. lappa), Imperata cylindrica Beauv.var.major (Nees) C.E.Hubb. (I. cylindrical var. 
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Imd pathway (16) . In order to determine whether extracts of these four medicinal plants can reduce Drosophila intestinal damage, AMP levels were analyzed (Dpt, Diptericin; Mtk, Metchnikowin) using qPCR. As shown in Fig. 3 , slightly increased AMP levels in the experimental groups were observed compared with the controls. In addition, Dpt and Mtk RNA levels were increased in the C. pilosula feeding group 16 h after SDS treatment, with 40-and 23.5-fold increases, respectively, compared with the control group. The extracts of S. lappa, I. cylindrical var. major and M. toosendan did not significantly affect the AMP levels in the Drosophila gut. Furthermore, the RNA levels of other AMPs (AttA, AttacinA; 
CecC, Cecropin C; Dro3, Dromycin-like peptides 3; Dfn, Defencin) were similar between groups (data not shown).
These results indicate that extracts of C. pilosula can induce high levels of Dpt and Mtk 16 h after treatment with SDS in the Drosophila gut.
Medicinal plant extracts do not increase SDS-induced ISC
proliferation in the midgut. Following ingestion of toxic compounds, including SDS or DSS, Drosophila ISCs increase their rate of proliferation in response to tissue damage (14) . To analyze the protective effects of the four different medicinal plant extracts, the esg-Gal4 UAS-GFP marker (for ISCs and EBs) was used to assess adult flies following treatment with 0.6% SDS. Furthermore, the numbers of ISCs and EBs were not significantly different between groups (Fig. 4) . This result indicates that these medicinal plant extracts do not induce stem cell proliferation in the Drosophila midgut in response to SDS.
Medicinal plant extracts are able to reduce SDS-induced cell death. In the Drosophila midgut, exposure to toxic compounds can increase apoptosis of epithelial cells (11 Medicinal plant extracts have protective effects against SDS-induced gut damage and morphological changes. It has previously been reported that SDS is able to induce melanotic tumors and morphological changes in the Drosophila gut (11) . Following treatment with 0.6% SDS for 4 days, the guts of control flies appeared shorter than that of the group that was fed with sucrose. Furthermore, melanotic tumors were observed in the posterior midguts of control flies (Fig. 6A) . However, the gut length of the C. pilosula-, S. lappa-, I. cylindrical var. major and M. toosendan extract-fed groups revealed significantly increased gut lengths compared with the control group, similar to the sucrose fed groups (P<0.001; Fig. 6A and B) . In addition, no melanotic masses were observed in the C. pilosula-, S. lappa-, I. cylindrical var. major-and M. toosendan extract fed groups (Fig. 6A ).
Discussion
Traditional medicinal plants have been effectively used with few side effects and over a long period of time (17) . However, due to the large number of diverse plant species and complex multicomponent systems, the active components and pharmacological functions of numerous of these plants have not been defined. Therefore, the use of these plants as sources of novel drugs must still be explored.
In order to screen the protective effects of medicinal plant extracts in vivo, Drosophila were used as a model organism, and adult flies were treated with toxic compounds. Of 50 different medicinal plant extracts, 8 and 9 species significantly increased the survival rates >70% compared with the controls following treatment with SDS or NaCl, respectively (Tables III and IV) . Among these extracts, however, a protective effect against SDS or NaCl was not identified. Furthermore, P. multiflorum Thunb., P. notoginseng (Burk) F. H. Chen, L. erythrorhizon Sieb. et Zucc. and C. rotundus L. protect against SDS-induced gut damage but do not increase the survival rate following NaCl treatment. This observation suggests that distinct mechanisms exist for these functions.
Medicinal plants that have broad protective effects against SDS and NaCl were selected for further investigation. Extracts of C. pilosula, S. lappa, I. cylindrical var. major and M. toosendan were used to examine their protective properties in the Drosophila intestine (Figs. 1 and 2) . Furthermore, C. pilosula can be used to invigorate the function of the spleen, which is beneficial to the liver and has anti-tumor, anti-oxidant and antimicrobial properties (18) (19) (20) (21) . Its primary constituents include polysaccharides, saponins, sesquiterpenes, polyphenolic glycosides, alkaloids, polyacetylenes, essential oils and phytosteroids (22) . S. lappa is a traditional herbal medicine that has been used to treat asthma, inflammation, rheumatism, coughs, tuberculosis and numerous other diseases (23) . It contains numerous sesquiterpene lactones, flavonoids, lignans, phenyl propanoids, alkaloids, triterpenes and phytosterols (24) . I. cylindrical var. major is commonly used as a diuretic and is an anti-inflammatory agent in traditional Chinese medicine (25) that exhibits diverse pharmacological activities, including cytotoxicity, neuroprotection and vasodilation (26) . However, its active compounds remain unclear. Furthermore, M. toosendan has been widely used for the treatment of malaria, stomach aches caused by round worms or as an anti-helminthic, antiseptic and anti-inflammatory analgesic. In addition, it primarily contains limonoids, toosen-danin and triterpenoid derivatives (27) .
Although the medicinal plants used in the present study have been previously explored, the majority of the results were limited to in vitro studies, with only a few researchers investigating their pharmacological roles in vivo (28, 29) . To the best of our knowledge, there are no references with regard to their protective effects in gut immunity. In the present study, high survival rates were observed in the experimental groups following treatment with toxic compounds. The previous studies indicated that following ingestion of pathogenic or toxic compounds, the proliferation of ISCs increased to replace dead cells, which was required for tissue homeostasis (14) . Following treatment with SDS, large numbers of 7-AAD-stained cells were detected in the control group, however, only a few dead cells were observed in the groups fed with plant extracts (Fig. 5) . These plant extracts decreased epithelial cell damage and melanotic tumor formation, protected the gut morphology and significantly improved the survival rates of adult flies following toxic compound treatment. However, there were no differences between groups with regard to stem cell proliferation (Fig. 4) . In addition, only extracts of C. pilosula significantly increased AMP levels following treatment with SDS for 16 h, whereas extracts of S. lappa, I. cylindrical var. major and M. toosendan were observed similar to the controls (Fig. 3) . The correlation between gut microbiota and the host immune system is important in the health of an organism, and the dysregulation of this balance can lead to chronic inflammation and initiate tumor formation (30, 31) . The extracts of S. lappa, I. cylindrical var. major and M. toosendan may contribute to the basal host immune system in the Drosophila intestine.
In summary, the present study provides a foundation for the effective screening of a large number of pharmacological functions from traditional medicinal plant extracts. The present study demonstrated that extracts of four different traditional medicinal plants (C. pilosula, S. lappa, I. cylindrical var. major and M. toosendan) have protective effects against gut disorders in Drosophila. These results may provide a pharmacological basis for the treatment of inflammatory bowel diseases in humans.
